How to go from scientist to venture capitalist: Bharat Srinivasa - Amplitudevc

1
00:00:00,000 --> 00:00:07,800
Hi everyone. Welcome to Learning with Rishad. My name is Rishad Usmani. I'm a physician,

2
00:00:07,800 --> 00:00:14,120
angel investor and founder of One Fail Startup. On this podcast, I talk about healthcare,

3
00:00:14,120 --> 00:00:17,920
investing in startups, venture capital, life and everything in between.

4
00:00:17,920 --> 00:00:23,480
Bharat, thanks for joining me today. I'm really excited for this conversation. To get started,

5
00:00:23,480 --> 00:00:28,600
I think our childhood shapes us to an extent. There are things from our childhood that we

6
00:00:28,600 --> 00:00:33,680
learned that contribute to our success, and there are things that we have to unlearn from

7
00:00:33,680 --> 00:00:39,160
our childhood to be successful. Talk to me about your childhood and what are some things

8
00:00:39,160 --> 00:00:44,920
that you learned that contributed and what are some things you had to unlearn?

9
00:00:44,920 --> 00:00:53,240
So let's start all the way back. I grew up in India, but also in the Middle East. And

10
00:00:53,240 --> 00:00:59,880
I basically jumped from one place to another every couple of years. And so every time it

11
00:00:59,880 --> 00:01:04,120
was a new experience where you start from scratch, build new friends, build new relationships

12
00:01:04,120 --> 00:01:13,280
and scale that up. The one consistency throughout all of that was my parents, obviously, but

13
00:01:13,280 --> 00:01:18,280
them saying, look, you do not have to be a doctor. You don't have to be an engineer.

14
00:01:18,280 --> 00:01:24,400
You don't have to be this. Do whatever you want. Be curious and that's fine. And so what's

15
00:01:24,400 --> 00:01:29,000
allowed me to stay true and make sure that I am who I am, I think is that curiosity from

16
00:01:29,000 --> 00:01:33,240
the beginning, which was you want to go study animals, let's go to the zoo. You want to

17
00:01:33,240 --> 00:01:36,680
go study plants, let's go to the forest. You want to study X, let's go to X, let's go to

18
00:01:36,680 --> 00:01:42,040
Y. So there was never a don't ask stupid questions, but if you're asking questions, let's give

19
00:01:42,040 --> 00:01:45,280
an answer. If you don't know what the answer is, let's go try to find that. That's something

20
00:01:45,280 --> 00:01:50,920
that I'm trying to inculcate in my own kids as well, that sense of curiosity. And that,

21
00:01:50,920 --> 00:01:56,040
I think has allowed me to continue what I'm doing now. The fact that I was also jumping

22
00:01:56,040 --> 00:02:01,160
from one place to another allows me to build relationships. And so for me, I'm very comfortable

23
00:02:01,160 --> 00:02:06,560
being outside of my comfort zone because that's how I was raised. When you're never comfortable,

24
00:02:06,560 --> 00:02:10,480
you're always looking for something new and therefore it allows you to get up to speed,

25
00:02:10,480 --> 00:02:15,440
become comfortable and really drive forward into different avenues in different areas.

26
00:02:15,440 --> 00:02:20,040
One thing that I'd like to fix, again, grew up in India, as I mentioned, as I think did

27
00:02:20,040 --> 00:02:27,240
you. And so the education system there is all about memorize this, study only this,

28
00:02:27,240 --> 00:02:32,000
answer only this. So it beats curiosity out of you to some extent, because all you need

29
00:02:32,000 --> 00:02:37,640
to do is pass the exam and you're done. And you can get a hundred percent and you're done

30
00:02:37,640 --> 00:02:40,520
if you get a 70 or a failure, blah, blah, blah. So that's something that I've had to

31
00:02:40,520 --> 00:02:44,280
try to get out, which is it's not about the marks, but it's about the process to get to

32
00:02:44,280 --> 00:02:49,560
the understanding of the subject and how you can explain that to somebody else in a manner

33
00:02:49,560 --> 00:02:52,840
that makes sense. If you can do that, then you're good and you've truly understood the

34
00:02:52,840 --> 00:02:57,200
subject. Thanks for that very informed answer, Bharath.

35
00:02:57,200 --> 00:03:02,800
And I have a million questions and I did grow up in India as well. One thing that moving

36
00:03:02,800 --> 00:03:09,640
a lot programmed in me was this need to move every two years. And anytime there's discomfort

37
00:03:09,640 --> 00:03:17,040
in my life, my answer is how I can change my environment. There's a few quotes in stoic

38
00:03:17,040 --> 00:03:22,800
philosophy and I'm going to butcher this, but essentially when you move or when you

39
00:03:22,800 --> 00:03:27,780
travel because you're uncomfortable, the problem is you, not your environment and you're taking

40
00:03:27,780 --> 00:03:33,420
you with you. So your new location, you will be uncomfortable as well. Is that something

41
00:03:33,420 --> 00:03:39,080
you experienced? Is that something you learned by moving a lot? And if so, how do you now

42
00:03:39,080 --> 00:03:46,640
find comfort in stability as opposed to comfort in new things and new environments?

43
00:03:46,640 --> 00:03:51,360
Yeah. I mean, when you're a kid, it's not like you have a choice in the matter, right?

44
00:03:51,360 --> 00:03:57,760
You move because you're moving. So it's really, you sink or swim and you figure it out. And

45
00:03:57,760 --> 00:04:04,720
I think what's that led to now is absolutely what you're saying, right? If something becomes

46
00:04:04,720 --> 00:04:13,240
comfortable or routine, I don't like it. And I start to get itchy. And whether it's detrimental

47
00:04:13,240 --> 00:04:16,880
or not, I try to break the pattern or break the routine. But sometimes it works, sometimes

48
00:04:16,880 --> 00:04:22,400
it doesn't. I think what I've done, and again, whether I'm successful or not, I have no idea,

49
00:04:22,400 --> 00:04:29,160
is I've tried to harness that in a manner that can help drive my career. I've been the

50
00:04:29,160 --> 00:04:33,120
CEO for a couple of companies and I didn't enjoy that because it's very, let's do one

51
00:04:33,120 --> 00:04:37,760
thing and one thing only. But as a VC now, what I get to do is jump across multiple different

52
00:04:37,760 --> 00:04:41,920
areas. So today I'm studying about cellular biology. Tomorrow I'm studying about gene

53
00:04:41,920 --> 00:04:44,960
therapy. Tomorrow I'm studying about, the day after I'm studying about something else.

54
00:04:44,960 --> 00:04:49,760
So you get shallow enough to understand it, but then you can jump to something else and

55
00:04:49,760 --> 00:04:58,440
drive that. So that to some extent keeps me excited, keeps me engaged, and gives me the

56
00:04:58,440 --> 00:05:02,280
new experience that I crave versus trying to become comfortable in one thing and just

57
00:05:02,280 --> 00:05:05,320
being one thing and doing that over and over again.

58
00:05:05,320 --> 00:05:11,520
Perfect. That's a great answer, Bharath. Let's talk about when to start on a new idea. Adam

59
00:05:11,520 --> 00:05:16,200
Grant talks about the sweet spot for success as moderate procrastination. So when you have

60
00:05:16,200 --> 00:05:21,360
a new idea, you think about it for a while and then you get started. And he phrases that

61
00:05:21,360 --> 00:05:28,540
in the schema that when you look at people who do best on exams, they're the ones who

62
00:05:28,540 --> 00:05:34,120
start early but don't submit to the last second. They're not the ones who are procrastinators

63
00:05:34,120 --> 00:05:40,720
or the ones who submit early. Do you yourself, do you have a proclivity to planning or a

64
00:05:40,720 --> 00:05:46,160
proclivity to action? I have a proclivity to action and a dangerous one at that. I started

65
00:05:46,160 --> 00:05:50,680
lots of big projects because I have somewhat of an ego and I think I will learn on the

66
00:05:50,680 --> 00:05:54,920
way. And I've found oftentimes it doesn't work out and there are things that require

67
00:05:54,920 --> 00:06:00,440
planning before you jump in. So I'd just love to hear from your perspective. Do you fall

68
00:06:00,440 --> 00:06:05,000
in the bias to action or the bias to planning? And which one do you think makes for a better

69
00:06:05,000 --> 00:06:07,000
investor and a better founder?

70
00:06:07,000 --> 00:06:19,400
I mean, bias to action by far. If it involves planning, if it involves sort of process,

71
00:06:19,400 --> 00:06:23,240
I'm not good at it because again, it goes back to routine. And for me, it's just, I

72
00:06:23,240 --> 00:06:29,240
have that fundamental issue with routine. I just cannot do it. Whereas, again, like

73
00:06:29,240 --> 00:06:36,080
you said, what I know I'm good at is figuring it out and figuring it out live to get to

74
00:06:36,080 --> 00:06:41,600
a solution. That I know I'm good at and that's why I tend to do that. Now, what does that

75
00:06:41,600 --> 00:06:46,360
lead to? You said, you said exams and submitting a sentence, stuff like that. That might be

76
00:06:46,360 --> 00:06:50,200
why I've never gotten a hundred or anything or a 90 or anything. I think the most I've

77
00:06:50,200 --> 00:06:56,600
ever got was like a 75, 80. And that shows in that. It's last minute, it's driven, it's

78
00:06:56,600 --> 00:07:02,400
good enough and it's good enough to get the job done and to move the needle forward. I

79
00:07:02,400 --> 00:07:07,600
think I still do that currently. If you're ever trying to get to a hundred, you will

80
00:07:07,600 --> 00:07:11,920
never get there. If you want to get to 90, you might get there, but the time commitment

81
00:07:11,920 --> 00:07:17,480
to get there is a lot. So the time commitment to get to 80 is, I'm just throwing in like

82
00:07:17,480 --> 00:07:22,280
two hours as an example. Time commitment to get to 90 is two more hours. Time commitment

83
00:07:22,280 --> 00:07:26,680
to get to a hundred is two more hours or three more hours or four more hours. Is it really

84
00:07:26,680 --> 00:07:32,360
worth that in order to get 20% more? I don't think so. So for me, I still follow that policy.

85
00:07:32,360 --> 00:07:36,960
Even in diligence, you can never get to a hundred percent. But if you are sufficient,

86
00:07:36,960 --> 00:07:40,240
if you know what's there, if you trust the team, if you know what you're doing, if they

87
00:07:40,240 --> 00:07:46,560
know what they're doing, make a bet and things will figure it out because over planning is

88
00:07:46,560 --> 00:07:53,160
pointless. The world is way too complex and way too heterogeneous for you to be able to

89
00:07:53,160 --> 00:07:55,760
plan to the dot and to the T.

90
00:07:55,760 --> 00:08:02,680
This is a very interesting answer and one that partly goes against other VCs. I would

91
00:08:02,680 --> 00:08:10,840
love to dig deeper into structured decision-making versus intuition in investing. And from whatever

92
00:08:10,840 --> 00:08:15,920
in the past, if it's not a hell yes, it's a no. Do you believe in that philosophy? And

93
00:08:15,920 --> 00:08:21,240
tell me about your process for decision-making when you're looking at pitch decks and when

94
00:08:21,240 --> 00:08:25,760
you're evaluating companies doing due diligence, how much of that is structure? How much of

95
00:08:25,760 --> 00:08:29,400
that is intuition?

96
00:08:29,400 --> 00:08:34,640
I would be lying if I told you I had the intuition of someone who's been doing this for 30, 40,

97
00:08:34,640 --> 00:08:41,160
50 years. I don't have that. I'm not that old. At the same time, structure-

98
00:08:41,160 --> 00:08:45,080
Our hairline lies, Bharat.

99
00:08:45,080 --> 00:08:54,840
At the same time, structure, I feel like structure is what's... It makes you feel that you're

100
00:08:54,840 --> 00:09:00,960
doing the right process, but if you do it that way, you're missing out a lot. So if

101
00:09:00,960 --> 00:09:05,280
you were only structured, that's a problem. If you're only intuition, unless you have

102
00:09:05,280 --> 00:09:08,440
30 years of experience, you're not there. So you have to balance that. You have to have

103
00:09:08,440 --> 00:09:13,000
some structure, but also have some intuition in order to drive that forward. So when I'm

104
00:09:13,000 --> 00:09:19,760
doing diligence, if it's a hell no, then it's a hell no. There's no way it's happening.

105
00:09:19,760 --> 00:09:25,840
There is a very, very rare chance that something is a hell yes. It just never happens. So for

106
00:09:25,840 --> 00:09:33,280
me, it's always, huh, that's interesting. Now that's interesting to me, I can tell,

107
00:09:33,280 --> 00:09:38,080
because I am reading all the time, and I'm reading absolutely everything on completely

108
00:09:38,080 --> 00:09:43,240
diverse subjects all the time. And so for me, I'm trying to make up intuition by reading

109
00:09:43,240 --> 00:09:47,960
as much as possible and just collecting information. So when I think something is interesting, it's

110
00:09:47,960 --> 00:09:50,880
because somewhere in the back of my mind, I think I have read something of somebody

111
00:09:50,880 --> 00:09:55,100
else doing something and raising capital and being successful and getting into patients.

112
00:09:55,100 --> 00:10:01,280
So I say, oh, how is this related to that? Let me dig in for you. And so I dig in a lot,

113
00:10:01,280 --> 00:10:06,000
but like we talked about, I don't dig into a hundred percent. I dig into 50, 60 percent.

114
00:10:06,000 --> 00:10:08,720
And that allows me to say, this is really interesting. And now I want to spend some

115
00:10:08,720 --> 00:10:14,200
more time to get from 50 to 80 percent and then drive in. And so for me, if I was structured,

116
00:10:14,200 --> 00:10:18,400
then I would say, oh, I have seen this company X, this company X has good management, good

117
00:10:18,400 --> 00:10:21,840
science, good this, therefore it is a good investment. And therefore I will do dollars.

118
00:10:21,840 --> 00:10:26,560
I mean, there are some funds that do that. There's a blank here on the name. There's

119
00:10:26,560 --> 00:10:32,800
an AI fund that looked at all of the successful investments in their past and effectively

120
00:10:32,800 --> 00:10:37,920
tried to make a decision based on what AI would tell you to do. I'm blanking on the name now.

121
00:10:37,920 --> 00:10:41,440
And I don't know if that's been super successful. And at the same time, those that are completely

122
00:10:41,440 --> 00:10:47,200
in the way, like I will figure it out live and make a bet and see what happens that hasn't

123
00:10:47,200 --> 00:10:50,920
successfully worked as well. I think it's somewhere in between. And your process in

124
00:10:50,920 --> 00:10:56,760
a career is to find the right balance between intuition versus deception.

125
00:10:56,760 --> 00:11:02,520
That is a fascinating answer. And I'm very happy I asked that question. Let's talk about

126
00:11:02,520 --> 00:11:08,480
your undergrad experience. So everything you've said, you have a bias towards action. You

127
00:11:08,480 --> 00:11:12,000
want to work on multiple projects at the same time. And I'm the same type. If you told me

128
00:11:12,000 --> 00:11:18,840
that, if you gave me your persona and my persona to an extent and said person A went to do

129
00:11:18,840 --> 00:11:24,320
a master's and a PhD and person B went to med school, I'd be like, no way. Their personality

130
00:11:24,320 --> 00:11:31,440
does not fit 10 plus years of education. And the reason I went to med school is A, just

131
00:11:31,440 --> 00:11:36,320
pressure from culture, from parents. And B, I didn't know what else to do. And this is

132
00:11:36,320 --> 00:11:44,120
a very weak answer, I think. Tell me more about your path to, if you're an undergrad,

133
00:11:44,120 --> 00:11:47,600
you have committed to four years and then you committed to two more years and then you

134
00:11:47,600 --> 00:11:54,360
commit to four more years. What are those decisions like? And do you think looking back,

135
00:11:54,360 --> 00:12:00,000
it was the right decision? Is 10 years too long? And I'll ask one more question on that.

136
00:12:00,000 --> 00:12:06,040
Does it make sense that every undergrad degree is four years? And this is the leading question.

137
00:12:06,040 --> 00:12:12,880
Does it make sense every master's is two years and every PhD is, you know, four to six years?

138
00:12:12,880 --> 00:12:20,640
Yeah, I mean, so I'll answer the last question first, because it's probably easier. You know,

139
00:12:20,640 --> 00:12:25,480
is an undergrad four years, is a master's two, is a PhD five? I think time is irrelevant

140
00:12:25,480 --> 00:12:32,680
there. It's more about what you want to get out of your academic degree. And in an undergrad,

141
00:12:32,680 --> 00:12:38,680
it is learning that there is a whole world out there, which school doesn't teach you.

142
00:12:38,680 --> 00:12:43,720
School teaches you do this, get marks and get out. Undergrad is well, for the first

143
00:12:43,720 --> 00:12:49,080
time, you're probably away from parents, you've got the world of education that you can do

144
00:12:49,080 --> 00:12:53,800
in terms of subjects and theses and blah, blah, blah. And you're working with other

145
00:12:53,800 --> 00:12:58,920
people that are similar to you and, you know, free birds effectively. So it's more about

146
00:12:58,920 --> 00:13:04,240
learning who you are as a person and learning about how to learn a little bit. And if that

147
00:13:04,240 --> 00:13:08,680
takes four years, it takes four. If it takes five, it takes five. Schools still tell you

148
00:13:08,680 --> 00:13:13,000
it's four. So whatever, it's fine. Right. That's the summer regiment that schools need

149
00:13:13,000 --> 00:13:17,760
to do. And that's where the four year comes from. Masters and PhDs are slightly different

150
00:13:17,760 --> 00:13:22,480
because there it's driven by what you get out of it. And in a master's, it's a thesis.

151
00:13:22,480 --> 00:13:30,840
In a PhD, it's a thesis and papers. Right. And so my master's was, you know, about 18

152
00:13:30,840 --> 00:13:37,640
to 20 month masters. And I'm happy to talk about sort of why I chose those as well. But

153
00:13:37,640 --> 00:13:42,600
my master's was 18 months. I got out with one paper. That is what I wanted. And out

154
00:13:42,600 --> 00:13:49,440
of my undergrad, I realized that, well, actually, let's take a step back. Out of high school

155
00:13:49,440 --> 00:13:54,000
and since grade six, I knew I wanted to go into biology. I don't know why, but I just

156
00:13:54,000 --> 00:13:58,520
knew I wanted to go into biology. I had no idea why. So I stayed in biology. 11th and

157
00:13:58,520 --> 00:14:03,040
12th was biology as well. I knew I didn't want to be a doctor from grade 12, but I didn't

158
00:14:03,040 --> 00:14:08,880
know what I wanted to do out of biology. And so from India, I applied, got into U of T.

159
00:14:08,880 --> 00:14:12,920
And I knew for some reason that, you know, immunology, microbiology sounds interesting.

160
00:14:12,920 --> 00:14:19,600
It kills bugs, kills people, kills animals, really no treatment against it. Why? Let's

161
00:14:19,600 --> 00:14:25,040
go figure it out. So I knew I wanted to go do that in undergrad. And then undergrad taught

162
00:14:25,040 --> 00:14:29,280
me that there's this whole other world of host pathogen relationships and human immunology

163
00:14:29,280 --> 00:14:33,240
that I had no idea before. So that's what I talked about undergrad being sort of exploding

164
00:14:33,240 --> 00:14:37,800
your mind. So master's was, okay, let's go learn human immunology. I tried to understand

165
00:14:37,800 --> 00:14:43,640
that. I got bored of human immunology, especially immune deficiencies. And I wanted to understand

166
00:14:43,640 --> 00:14:50,320
viruses and immunology. And so why did you get bored of human immunology?

167
00:14:50,320 --> 00:14:55,200
Because human immunology, it's very, it's very, you know, it's the same reason I didn't

168
00:14:55,200 --> 00:15:01,400
want to go into med school. It's here is the knowledge, right? It is here's anatomy. The

169
00:15:01,400 --> 00:15:06,120
bone is the bone. You cannot change anything. Physiology is physiology. You cannot change

170
00:15:06,120 --> 00:15:09,720
anything. Human immunology is human immunology. You cannot change anything. So it's more about

171
00:15:09,720 --> 00:15:13,800
learning T cells and B cells and this and that and that. For me, what got excited is

172
00:15:13,800 --> 00:15:18,000
how do you, and maybe this goes back to what we talked about, how do you disrupt, how do

173
00:15:18,000 --> 00:15:22,240
you disrupt a routine? And for me, I love viruses and bacteria because it goes in and

174
00:15:22,240 --> 00:15:26,760
disrupts that routine of the human clock, the human immunology clock by changing it

175
00:15:26,760 --> 00:15:31,040
completely. And so I was really curious about that. And I wanted to go learn that. And so

176
00:15:31,040 --> 00:15:36,560
I finished my master's, went and did a PhD. During my PhD, I decided I didn't want to

177
00:15:36,560 --> 00:15:41,760
be an academic. I didn't like writing grounds. I wasn't good at it. I hated working in the

178
00:15:41,760 --> 00:15:48,480
lab. So what could I go and explore outside that? My PI was supportive. So I finished

179
00:15:48,480 --> 00:15:55,720
my PhD in three and a half years and got out of that two papers, a review, and the knowledge

180
00:15:55,720 --> 00:16:03,280
of what I knew and what I didn't know. So to answer your question, is the time a component?

181
00:16:03,280 --> 00:16:07,240
I think time is irrelevant, at least from a master's and PhD level. It's what you want

182
00:16:07,240 --> 00:16:12,200
to get out of that. That really drives that. I ranted about this part, so I forgot the

183
00:16:12,200 --> 00:16:16,280
first part of your question. So if you want to repeat that, I can answer that again.

184
00:16:16,280 --> 00:16:21,240
You're putting the pressure on me, Bharat. I think my first part of the question was,

185
00:16:21,240 --> 00:16:28,000
do you regret the amount of time you spent in school? And looking back, ask a different

186
00:16:28,000 --> 00:16:33,000
question. What piece of advice would you give to Bharat in undergrad? And would you advise

187
00:16:33,000 --> 00:16:37,360
him to do anything differently in terms of your master's and PhD? And we'll talk about

188
00:16:37,360 --> 00:16:39,960
post-PhD after.

189
00:16:39,960 --> 00:16:48,360
Honestly, what I would have told myself from 10 years ago was, get outside experience rather

190
00:16:48,360 --> 00:16:55,200
than just academics. Because for me, I'm paying a lot of money to come to do this undergrad

191
00:16:55,200 --> 00:17:02,560
degree as an international student. And so I need to make it worth it. And so let me

192
00:17:02,560 --> 00:17:07,360
go choose the classes that I think will help me in the future. So I went and did immunology,

193
00:17:07,360 --> 00:17:11,080
and I went and did class X and class Y. When there were easier classes available, I chose

194
00:17:11,080 --> 00:17:16,560
the harder classes just because I have to... It cost me 2,000 bucks for a class. I may

195
00:17:16,560 --> 00:17:21,800
as well get something on it. So it was very sort of, I'm thinking of that, and therefore

196
00:17:21,800 --> 00:17:27,720
I need to choose it now. And so there were a lot of experiences that... Well, we went

197
00:17:27,720 --> 00:17:31,000
to undergrad together so we can talk about it. But there were a lot of experiences that

198
00:17:31,000 --> 00:17:37,920
we had as undergrads that I think were more academically driven than learning about yourself

199
00:17:37,920 --> 00:17:43,800
as a person that I feel like I missed out on sometimes. But on the other side, it made

200
00:17:43,800 --> 00:17:46,000
me who I am.

201
00:17:46,000 --> 00:17:53,680
And when did you learn about yourself as a person?

202
00:17:53,680 --> 00:17:59,120
You're always learning who you are as a person. I don't think you're ever done with that.

203
00:17:59,120 --> 00:18:07,520
But it boils down to, I know I can get shit done and I know I can figure it out. So that's

204
00:18:07,520 --> 00:18:11,840
something that I learned during my undergrad. When you have assignments due tomorrow and

205
00:18:11,840 --> 00:18:17,640
you're starting today and you need to do it, you just get shit done. And it doesn't matter.

206
00:18:17,640 --> 00:18:20,920
You just need to pass, you need to get 75. And I knew I could get 75. So let's just do

207
00:18:20,920 --> 00:18:22,400
it that way and get 75.

208
00:18:22,400 --> 00:18:29,840
Okay. I know there's a lot of physicians who listen to this and a lot of academics as well.

209
00:18:29,840 --> 00:18:36,320
What advice do you have for them if they want to venture out of academics and medicine and

210
00:18:36,320 --> 00:18:42,160
into the world of investing venture capital? And I'd love for you to talk about your path

211
00:18:42,160 --> 00:18:45,360
post PhD into venture capital.

212
00:18:45,360 --> 00:18:53,280
Yeah. Honestly, the one piece of advice is just do it. You're in a world right now where

213
00:18:53,280 --> 00:18:57,840
there are so many investors and they're always looking for advice. So if you reach out to

214
00:18:57,840 --> 00:19:04,560
someone and say, Hey, I'd like to learn more, they will never say no. So always reach out

215
00:19:04,560 --> 00:19:09,680
and just have a conversation with them. Right. Having conversations with people is what got

216
00:19:09,680 --> 00:19:14,080
me to where I am now. And so get out of your comfort zone and just reach out and talk to

217
00:19:14,080 --> 00:19:22,080
people. You don't have to make a commitment, but talking to someone is not that difficult.

218
00:19:22,080 --> 00:19:29,320
My pathway is, I talked about undergrad masters. In my undergrad, I thought I wanted to be an

219
00:19:29,320 --> 00:19:35,480
academic, went into the masters, realized I didn't want to be an academic. Thought I'd

220
00:19:35,480 --> 00:19:41,200
go into consulting because it was science, but also doing other stuff. Applied to a bunch

221
00:19:41,200 --> 00:19:49,320
of consulting shops. I had no outside experience in real life work experience and thought,

222
00:19:49,320 --> 00:19:54,120
okay, you know what? PhD makes sense. I had this curiosity. Let's go figure that out.

223
00:19:54,120 --> 00:20:00,200
But I didn't want to go just to any PhD. I knew exactly which PI I wanted. And I basically,

224
00:20:00,200 --> 00:20:05,880
this is funny. I emailed him about five or six times. He never responded. So one day

225
00:20:05,880 --> 00:20:09,080
I said, you know what, screw it. I know where his lab is. I'm just going to go meet him

226
00:20:09,080 --> 00:20:13,560
in the lab. And I just started walking down the hallway. This is at Negril at the Montreal

227
00:20:13,560 --> 00:20:18,840
General Hospital. I was just walking to his lab and I think he was heading home. And I

228
00:20:18,840 --> 00:20:21,800
just literally stopped him on the hallway and I'm like, Hey, I sent you some emails.

229
00:20:21,800 --> 00:20:25,080
I'd like to chat about a PhD blah, blah, blah. He's like, yeah, just come tomorrow and let's

230
00:20:25,080 --> 00:20:30,040
chat. So I went there tomorrow. I went there the next day. I started talking about why

231
00:20:30,040 --> 00:20:34,200
I wanted to do this. Told him, look, I want to do science, but I don't want to be a scientist.

232
00:20:34,200 --> 00:20:39,160
I want to go do something else. I don't want to be an MD, blah, blah, blah. And it's right

233
00:20:39,160 --> 00:20:45,720
time, right place, right person kind of thing. He was looking for a PhD student. He was working

234
00:20:45,720 --> 00:20:52,040
for a, you know, he was a chief medical officer at a medical vaccine, biotech vaccine company.

235
00:20:52,040 --> 00:20:56,200
And they were looking to do something in the respiratory virus space. And I said, I wanted

236
00:20:56,200 --> 00:21:00,040
to go do get industry experience. So it's sort of right time, right place. And I ended up joining

237
00:21:00,040 --> 00:21:06,120
his lab as a PhD. Told him, look, I want to get out. I don't know what I want to get out and do.

238
00:21:06,120 --> 00:21:10,520
I think consulting, but I want to go do that. Yeah, that's fine. Let's figure it out.

239
00:21:10,520 --> 00:21:16,120
So started working on my project during my PhD. You have a lot of downtime, and this is

240
00:21:16,120 --> 00:21:21,480
embarrassing, but you have a lot of downtime when waiting for experiments. So I watched a lot of TV.

241
00:21:21,480 --> 00:21:26,520
And I think this was at the time where Shark Tank was starting to be popular. And I was watching a

242
00:21:26,520 --> 00:21:30,840
lot of Shark Tank. And I'm like, huh, that's cool. Wait, so you can put money into ideas and see if

243
00:21:30,840 --> 00:21:36,680
that works. That sounds really cool. And so I talked to a bunch, I just reached out to a bunch

244
00:21:36,680 --> 00:21:43,000
of VCs during my PhD. And they all said, look, you have no experience in the real world. Just

245
00:21:43,000 --> 00:21:47,160
go out, get some real world experience and come back and let's talk. And what are you messaging

246
00:21:47,160 --> 00:21:54,040
them? Like what's in the email? It was just, listen, I'm a PhD student. So I was careful. I

247
00:21:54,040 --> 00:22:01,560
only messaged VCs who were also PhDs. And my ask of them was, hey, look, PhD, trying to get into

248
00:22:01,560 --> 00:22:07,320
VC, love to learn more about you. Do you have 30 minutes? And I sent about five or six emails,

249
00:22:07,320 --> 00:22:12,520
got rejected from most of them. One person or two people responded. They then connected me with

250
00:22:12,520 --> 00:22:18,600
someone else and that expanded my network. So I just did that. They also get some real world

251
00:22:18,600 --> 00:22:23,320
experience and come back. So I said, okay, how do I get real world experience when I'm doing my PhD?

252
00:22:23,320 --> 00:22:29,160
So then I cold emailed the Megal Tech Transfer Office and said, look, I'm free labor.

253
00:22:29,160 --> 00:22:35,720
I think I'm helpful. Can I come help you out? And again, they said, yeah, sure. Free labor.

254
00:22:35,720 --> 00:22:39,720
What's there to do? Just come over and help you out. So I did that for a few months with them.

255
00:22:41,880 --> 00:22:46,760
My project out of my PhD, I said, this is an idea. I should go try starting a company around this,

256
00:22:46,760 --> 00:22:52,520
if I really want to go be a VC. So talked to the same VCs and they all, they basically laughed it

257
00:22:52,520 --> 00:22:57,160
out of the room. You have no experience, they're terrible people. They're terrible people.

258
00:22:57,160 --> 00:23:01,240
You have no experience, they're a terrible idea. It's going to cost a lot. Clinical trials are

259
00:23:01,240 --> 00:23:05,320
expensive, blah, blah, blah. So I said, huh, okay. That's fine. At least I tried something.

260
00:23:05,320 --> 00:23:12,520
If it failed, it failed school. So finished my PhD, got the papers, graduated as I mentioned,

261
00:23:12,520 --> 00:23:16,760
three and a half years, and then went into healthcare consulting for a few years.

262
00:23:18,440 --> 00:23:22,760
Didn't enjoy healthcare consulting as much because it was very sort of, here is a process.

263
00:23:22,760 --> 00:23:26,920
You have to do this project and you have to do it in this exact manner and you have to get this

264
00:23:26,920 --> 00:23:31,400
deliverable and you give this deliverable to somebody else. And they say, yeah, I don't like

265
00:23:31,400 --> 00:23:36,600
the answer. Just double the revenue projection. Okay. There you go. So you're sort of doing it

266
00:23:36,600 --> 00:23:40,760
for somebody else and it's very, you know, Excel files are going to be perfect and everything has

267
00:23:40,760 --> 00:23:46,280
to be perfect and designed and all of that crap. But I did that for a couple of years. It really

268
00:23:46,280 --> 00:23:51,480
helped me learn about the VC space, sorry, about the biotech space, the industry and all of that.

269
00:23:51,480 --> 00:23:55,640
But still kept in touch with my VC connections and would send them an email every six months,

270
00:23:55,640 --> 00:24:00,920
like, Hey, this is what I'm doing. This is what I'm doing. And out of the blue, so one of the

271
00:24:00,920 --> 00:24:08,840
people that I emailed to, this was at the business development bank of Canada, the BDC. She emailed

272
00:24:08,840 --> 00:24:14,600
saying, we have a job opening now. Are you interested? I'm like, sure. Can you send me

273
00:24:14,600 --> 00:24:18,840
the posting? She's like, yeah, the posting expired two weeks ago, but just send it to me and send me

274
00:24:18,840 --> 00:24:25,000
a resume. So I said, sure. So I send my resume. And I think within like 10 minutes, they said,

275
00:24:25,000 --> 00:24:30,440
yeah, just come and have a first chat with us. I had a first chat, went through the process and

276
00:24:30,440 --> 00:24:35,160
then got hired. I think there was, I was the only one hired out of like three or 400 people. But

277
00:24:35,160 --> 00:24:41,080
when I was going through that process, I would go to work, come back at like 5pm. And then from

278
00:24:41,080 --> 00:24:45,080
five to nine, I would just learn everything I could about VC or whatever I could about VC.

279
00:24:45,080 --> 00:24:51,880
Because again, it goes back to, I knew I could figure it out. So let me go figure out what VC was.

280
00:24:51,880 --> 00:24:57,160
And then I did that. And how are you learning Bharat? Like are you taking courses, reading books,

281
00:24:57,160 --> 00:25:02,120
YouTube videos? I'm just reading, just reading as much as possible. I mean, Google is amazing in

282
00:25:02,120 --> 00:25:06,200
that there's literally anything and everything that you can think or think of and find. So I

283
00:25:06,200 --> 00:25:10,760
would just read everything about VC that I could. I still made a shit ton of mistakes during my

284
00:25:10,760 --> 00:25:19,560
interview, but I knew how to fake it sounds terrible, but I knew how to talk my way through

285
00:25:19,560 --> 00:25:27,800
anything. And that part of what I did and acted like I knew enough to be curious, which I was,

286
00:25:27,800 --> 00:25:31,960
but also enough to say, I don't know this and this is what I want to learn. This is how to drive it

287
00:25:31,960 --> 00:25:38,440
forward. And then there were a couple of experiences like me trying to start my company and what,

288
00:25:38,440 --> 00:25:44,200
you know, I have a lot of opinions about everything. And VC is partly an opinion role,

289
00:25:44,920 --> 00:25:49,560
at least in terms of by the company to learn. And I shared a lot of those opinions in my interviews

290
00:25:49,560 --> 00:25:54,920
and backed them with facts. And that allowed me to get the role. And many things happened after that.

291
00:25:57,080 --> 00:26:02,440
Let's go deeper into many things happened after that. I think it's very interesting how you went

292
00:26:02,440 --> 00:26:10,680
from that to starting Amplitude. If you're open to it, talk me more about that journey.

293
00:26:11,880 --> 00:26:17,000
And maybe you can frame it in a way on what are things you might do differently if you were to do

294
00:26:17,000 --> 00:26:29,560
it again. Yeah. So to do things differently is a loaded question because I have no idea whether

295
00:26:29,560 --> 00:26:33,320
I'll be successful or not, whether Amplitude will be successful or if anything we do is successful

296
00:26:33,320 --> 00:26:37,320
or not. And so when you're in the midst, it's really hard to know whether you're going up or

297
00:26:37,320 --> 00:26:41,400
going down. You're just there. And so it's hard to say I would have done something differently

298
00:26:41,400 --> 00:26:45,880
because you have no idea. It's only when you fail or you're successful that that'll happen.

299
00:26:45,880 --> 00:26:50,360
But I'll walk you through the process and maybe that'll answer some of that question.

300
00:26:52,360 --> 00:26:56,200
So I went through that interview process, got into the BDC Healthcare Venture Fund,

301
00:26:56,200 --> 00:27:02,440
joined as an analyst. I had no idea what we see. I was pretending day one.

302
00:27:02,440 --> 00:27:09,960
And we'd be having these sort of... Our team was spread out across Montreal, Toronto,

303
00:27:09,960 --> 00:27:16,040
and Vancouver, and San Francisco. So we were having virtual calls. And people would say

304
00:27:16,040 --> 00:27:20,600
something and I would just be Googling what is that on the site so that I could act like I knew

305
00:27:20,600 --> 00:27:23,560
what I was talking about. So they'd be like, oh yeah, and the preferred shares, blah, blah, blah.

306
00:27:23,560 --> 00:27:27,480
What are preferred shares? And Google it and read quickly and say, oh yeah, yeah, that makes sense.

307
00:27:28,600 --> 00:27:32,840
And so it was sort of, you're learning by yourself and that's effectively what we see as always.

308
00:27:32,840 --> 00:27:38,520
You're thrown into the deep end, go and help a company and you just do it. And meet as many

309
00:27:38,520 --> 00:27:46,600
companies as possible. So I did that for a couple of years. This was also the time where we had

310
00:27:46,600 --> 00:27:51,480
already at the BDC completely invested into all of our companies. A lot of our companies were doing

311
00:27:51,480 --> 00:27:56,440
follow on rounds of financing and they were going public as well. So I worked with the partners to

312
00:27:57,160 --> 00:28:03,160
understand what those follow on deals look like. How to take companies public. I spent a lot of

313
00:28:03,160 --> 00:28:08,680
time reading legal documents because I figured that can help differentiate me because everybody

314
00:28:08,680 --> 00:28:14,360
has a science background, but there's very few lawyers and scientists. So if I can understand

315
00:28:14,360 --> 00:28:18,680
the legal stuff, I can negotiate my way out of anything. So I spent a lot of time looking at

316
00:28:18,680 --> 00:28:22,760
that. Spent a lot of time looking at absolutely everything under the sun in terms of biology,

317
00:28:22,760 --> 00:28:29,560
just reading as much as I could. And then when we were already at the BDC, there were some

318
00:28:29,560 --> 00:28:33,960
discussions around we should be spinning out. So there were early conversations happening already.

319
00:28:35,160 --> 00:28:42,600
So me and three others, we started putting the plans together in terms of, this is how you build

320
00:28:42,600 --> 00:28:46,760
a model for spinning out. This is our strategy. This is a thesis. This is our plan. This is the

321
00:28:46,760 --> 00:28:52,760
portfolio. This is the deals, blah, blah, blah. So spent 2015 to about 2016 was me just learning

322
00:28:52,760 --> 00:28:57,240
and doing follow-ons and stuff like that. In 2017 in earnest, we started the whole process

323
00:28:57,240 --> 00:29:02,680
of spinning out. So that took about 2017 and part of 2018 where you're just putting together the

324
00:29:02,680 --> 00:29:06,440
packages and trying to understand and explain why we should spin out. What are theses? How do you

325
00:29:06,440 --> 00:29:13,160
launch a new fund? Who do you launch a fund with? What companies exist? All of that. We spun out in

326
00:29:13,160 --> 00:29:22,200
mid 2018 to launch Amplitude, me and three others. We were fortunate enough that we had a term sheet

327
00:29:22,200 --> 00:29:30,360
for the new fund and that we had a commitment from BDC to kickstart the fund, but no other dollars

328
00:29:30,360 --> 00:29:36,680
and no dollars in the bank. We were still managing the portfolio for the BDC and we were getting some

329
00:29:36,680 --> 00:29:44,280
income from there in order to support our lives and all of that. So that was 2018. We spent about

330
00:29:44,280 --> 00:29:50,840
a year and a half fundraising, but the first fund takes forever to close because no one knows who

331
00:29:50,840 --> 00:29:55,000
the hell you are, whether your thesis works, et cetera. But we were lucky that the two partners

332
00:29:55,000 --> 00:30:02,360
were well known in the ecosystem. I was starting to become well known in the ecosystem and the

333
00:30:02,360 --> 00:30:07,800
packages that we had put together resonated and our thesis resonated. And so we did our first close

334
00:30:07,800 --> 00:30:16,680
in 2019, November. Then did subsequent closes to get to the rest of the money by 2020, 2021.

335
00:30:19,480 --> 00:30:25,320
You followed a path that in my limited knowledge is not traditional, where most people will start

336
00:30:25,320 --> 00:30:31,240
an initial fund, five to 10 million, then 30 million, and then go to the nine-figure fund.

337
00:30:31,240 --> 00:30:37,160
You started at the end, Barth, or you jumped to one, two, three, and you started at step four,

338
00:30:37,160 --> 00:30:43,000
it looks like. And your first raise was from institutional investors or LPs, which is incredibly

339
00:30:43,000 --> 00:30:53,720
rare and only a very select few are able to do that. What made you in particular so good at that?

340
00:30:54,280 --> 00:31:00,200
Why were these institutionals willing? What did you prove to them or show them?

341
00:31:00,200 --> 00:31:07,800
Well, it's not me. I can't take the credit for this. This is my team that did it. And the two

342
00:31:07,800 --> 00:31:12,520
partners had been in the industry for 20 plus years, so they knew a lot of people that trust

343
00:31:12,520 --> 00:31:19,560
existed. But I think what allowed us to be more successful in spinning out was when we started or

344
00:31:19,560 --> 00:31:26,040
when we were at the BDC, what existed in the Canadian ecosystem in terms of VC investments then

345
00:31:26,040 --> 00:31:31,720
was microchecks and the death by a thousand cuts. Here's a hundred thousand, here's a million,

346
00:31:31,720 --> 00:31:40,600
here's a two million. A very strong sense of risk aversion and spending dollars towards doing deals.

347
00:31:41,240 --> 00:31:46,440
What we did at the BDC that was different, and everything is timing, everything is luck,

348
00:31:46,440 --> 00:31:51,080
everything is not really in your control. But what we tried to do was say, look,

349
00:31:51,080 --> 00:31:57,480
that strategy doesn't work. Let's do fewer deals, but let's put a lot of money behind those deals.

350
00:31:58,120 --> 00:32:01,640
Because if we think they are going to be successful, let's give them the best chance of success.

351
00:32:01,640 --> 00:32:07,320
If it fails, you know what? It's fine. But if we're successful, we'll be successful. We did that at

352
00:32:07,320 --> 00:32:15,800
the BDC. A company called ZymeWorks, which we led the crossover around and took public. We put 10

353
00:32:15,800 --> 00:32:23,560
million US as a first check that had never been done in BDC's history until then. The IPO, we put

354
00:32:23,560 --> 00:32:27,240
another 10 million in and everyone said, wait, it's an IPO. You should be exiting. You're like, no,

355
00:32:27,240 --> 00:32:32,760
no, no. Biotech is different. IPO is where you invest and have the companies get up. So 20 million

356
00:32:32,760 --> 00:32:40,520
US in one company out of $135 million Canadian fund. It's a lot of money. Another company called

357
00:32:40,520 --> 00:32:47,160
Climantia, one of the partners that founded from scratch, really strong management team. But

358
00:32:48,200 --> 00:32:53,720
everything was chugging along, doing well. We had, I think, close to $20 million in that company

359
00:32:54,840 --> 00:33:01,800
when they went public, US again. And everything worked out. Company went public. Ipsum ended up

360
00:33:01,800 --> 00:33:06,600
buying them for 1.3 billion and we made effectively the entire fund and more with that.

361
00:33:06,600 --> 00:33:11,880
Now those companies and a couple of others were also the first companies in 10 or 12 years in

362
00:33:11,880 --> 00:33:17,800
Canada to go public on the US stock exchange and not the Canadian stock exchange. So we were always

363
00:33:17,800 --> 00:33:22,600
driven towards, let's try to do something different. Let's not follow routine just because it's been

364
00:33:22,600 --> 00:33:28,680
done before. Let's change the status quo. Let's see what happens. Let's put more money into fewer

365
00:33:28,680 --> 00:33:33,640
companies. Let's really give them the best chance of success. Let's take them public. If it works

366
00:33:33,640 --> 00:33:37,560
out, it works out. If it doesn't, whatever. You're smart enough, we'll find another job.

367
00:33:38,520 --> 00:33:45,000
That's when it worked out. And so that allowed us to go and talk to our LPs, talk to our VCs,

368
00:33:45,000 --> 00:33:53,240
do all of that and actually raise fund one. What we also had was, again, timing. The BDC was

369
00:33:53,240 --> 00:33:59,320
looking to spin out a couple of funds, the healthcare fund and the IT fund. And they gave

370
00:33:59,320 --> 00:34:05,720
us a cornerstone check that was effectively 50% of our first close. Because they said, look,

371
00:34:05,720 --> 00:34:09,320
if you were internally, we'd have to give you double that. If you're external, we'll give you

372
00:34:09,320 --> 00:34:13,480
half of that, but you have to raise the rest of the money. So we'll give you a chance, go figure it

373
00:34:13,480 --> 00:34:18,280
out. So we did that. And again, we had the knowledge, we had the track record, we had the

374
00:34:18,280 --> 00:34:25,400
experience in order to get that done. And it's still in the process. So we've closed fund one.

375
00:34:25,400 --> 00:34:30,840
In the process of raising fund two, we did a first close late last year. I haven't disclosed much

376
00:34:30,840 --> 00:34:34,760
about that, but now investing on a fund two, that'll be bigger than fund one.

377
00:34:35,560 --> 00:34:42,040
Congratulations. You know, marrying what you said before about not everything is a hell yes,

378
00:34:42,680 --> 00:34:51,480
and 80% is good for an investment, to investing in a few select companies at these massive

379
00:34:51,480 --> 00:34:58,920
massive eight figure checks is very scary, to be frank. And I wonder if your 80%

380
00:35:01,080 --> 00:35:06,040
is a hell yes for 90% of the people. I won't ask you to comment on that because it's a very

381
00:35:06,040 --> 00:35:15,240
loaded question. But what I will ask you to comment on is, is it harder to get access to great deals,

382
00:35:15,240 --> 00:35:21,960
or to recognize them when you see them? And what makes a great deal obvious? And how fast can you

383
00:35:21,960 --> 00:35:34,120
recognize one at this point? I mean, there are some great deals that are obvious. The problem

384
00:35:34,120 --> 00:35:40,440
is the valuation for that are going to be ridiculous. Right? And if your job is to make

385
00:35:40,440 --> 00:35:46,520
multiples of your dollars, that's going to be difficult by going after only great deals and

386
00:35:46,520 --> 00:35:57,160
paying at that valuation. So by default, I think this is maybe it's a mindset thing, but by default,

387
00:35:57,160 --> 00:36:01,080
I know that there is a very high probability that the company I'm going to do will fail.

388
00:36:02,440 --> 00:36:06,840
And so when I make that investment, I have that in the back of my mind,

389
00:36:06,840 --> 00:36:11,560
but I try to think of what are the reasons it'll fail and try to backfill that. So for me,

390
00:36:11,560 --> 00:36:19,640
when I say diligence, I am nowhere close to being an expert in the science. So I, to some extent,

391
00:36:19,640 --> 00:36:25,400
will trust what the CSO, the scientific team, et cetera, tells me. And I'll verify it. So I'll

392
00:36:25,400 --> 00:36:29,560
trust, but verify, and then spend more time thinking about the potential downsides and how

393
00:36:29,560 --> 00:36:37,320
to account for the downsides. And so for me, when do I ever say, hell yes, I don't know why, but

394
00:36:37,320 --> 00:36:41,640
there are some technologies that I look at and I'm like, holy shit, that's cool. And so for me,

395
00:36:41,640 --> 00:36:46,440
I maybe that's my, I haven't really thought about this, but to me, maybe that's my criteria. If I

396
00:36:46,440 --> 00:36:51,320
look at some science and I say, holy shit, that's cool. And I want to spend time learning about it,

397
00:36:51,880 --> 00:36:57,240
that gets me excited. Whereas if I see a company and we see like a hundred companies, 200 companies

398
00:36:57,240 --> 00:37:02,840
involved, there are majority of those companies are just me too's or they say, look, somebody else

399
00:37:02,840 --> 00:37:06,120
did that. We can do that. Somebody else did that. We can do that. That's just not exciting. So when

400
00:37:06,120 --> 00:37:10,520
I see something that's really cool, that automatically gets me excited and makes me want to work on that.

401
00:37:12,040 --> 00:37:19,080
And does it happen often? And if I think something is cool, there's definitely somebody else who

402
00:37:19,080 --> 00:37:23,480
thinks it's cool. And so then again, you're getting into this valuation game and all of that.

403
00:37:23,480 --> 00:37:28,360
So when you build a portfolio, you have to balance out sort of good companies,

404
00:37:29,000 --> 00:37:34,680
D-list companies, and some more risky companies. By default, when I say risky, D risky, it's more

405
00:37:34,680 --> 00:37:40,280
higher valuation, lower valuation in order to make sure that's successful. What I have done more

406
00:37:40,280 --> 00:37:46,760
recently is just started my own companies. I've been the CEO of one, I'm the pseudo CEO of another

407
00:37:46,760 --> 00:37:52,680
and working with an EIR for the third one all at the same time. Because I saw some science,

408
00:37:52,680 --> 00:37:55,880
I thought, holy shit, that's really cool. Let's try to start a company around that.

409
00:37:56,440 --> 00:38:00,040
And then raise the capital, build the team and do that. So I did that once, handed it over to our

410
00:38:00,040 --> 00:38:05,000
full-time management team. Doing that for another company at the moment now. And then the third

411
00:38:05,000 --> 00:38:09,640
company in EIR, so an entrepreneur in residence came to us and said, I've got this idea. So that

412
00:38:09,640 --> 00:38:15,080
sounds interesting. Plus you've got the experience. Let's go figure it out. This is going to sound

413
00:38:15,080 --> 00:38:24,760
terrible as VC, but I am okay losing $500,000 a million in an early stage idea. Because if it's

414
00:38:24,760 --> 00:38:32,040
successful, it'll pay out a lot. And it'll allow me, because in the end we're money managers,

415
00:38:32,040 --> 00:38:39,800
I have to be able to put 20 million into a company to make 50 million. And so I'm okay losing 500K

416
00:38:39,800 --> 00:38:43,720
with the option to put 20 million if it's successful versus putting 20 million at a

417
00:38:43,720 --> 00:38:49,320
high valuation. Because biology is biology and the risk of biology is always going to be the same.

418
00:38:49,960 --> 00:38:57,800
So let's just do that. And what's your deal flow like Parth? Are most of your deals through warm

419
00:38:57,800 --> 00:39:04,520
intros the ones you do invest in or is it cold outreach? How are you getting deal flow?

420
00:39:05,560 --> 00:39:09,240
I mean, I don't think I've ever done a deal that came out of a cold outreach.

421
00:39:09,240 --> 00:39:17,640
It's difficult. There's a lot of other things that play there when something comes in as a

422
00:39:17,640 --> 00:39:23,240
cold outreach that makes you question it. There's almost always warm outreaches,

423
00:39:23,240 --> 00:39:31,640
people that I know, people that I trust, academics that I trust, etc. That usually lets me do a deal

424
00:39:31,640 --> 00:39:38,120
or drives a deal. I'll ask a selfish question. Recently, I've come across a couple startups

425
00:39:38,120 --> 00:39:43,480
that I'm excited about, but they were born out of university accelerators. So the university

426
00:39:43,480 --> 00:39:51,480
itself collects royalties, 2% to 5% for 7 to 10 years in my case. How do you look at that? And

427
00:39:52,280 --> 00:39:57,720
is that a positive or a negative in your mind if a startup is born out of a university accelerator?

428
00:39:58,840 --> 00:40:07,080
No, I mean, if the biology of the technology, whatever is good, I think that's fine. Royalties,

429
00:40:07,080 --> 00:40:12,200
2% to 5%, 7%, okay, how you negotiate that is important, but that's pre-market.

430
00:40:13,560 --> 00:40:19,320
And I have no issues with that. For me, again, it boils down to what's the biology and how cool is

431
00:40:19,320 --> 00:40:25,800
it? Again, I say biology because we do more biotech, but how is the technology? And is that

432
00:40:25,800 --> 00:40:31,960
solving a problem? And is it differentiated from the others solving a problem? Because in the end,

433
00:40:31,960 --> 00:40:37,720
what you're paying for and what you're buying is that differentiation. And so is that differentiation

434
00:40:37,720 --> 00:40:44,200
truly worth it? And does the management team know how to solve that differentiation problem?

435
00:40:45,160 --> 00:40:51,400
So where it comes from, it doesn't matter. Any legal contract can be renegotiated.

436
00:40:53,080 --> 00:40:58,920
And so if it needs to be, it can be. Again, then the relationships matter and that's something that

437
00:40:58,920 --> 00:41:05,080
we'll figure out over time. Okay. Let's talk about founder equity. I recently passed on a deal

438
00:41:05,080 --> 00:41:11,720
that looked great on paper. They had a good sales pipeline coming up, good contracts already.

439
00:41:12,920 --> 00:41:18,040
They were being valued at 10x their ARR, which is for a pre-seed. I think that's pretty good.

440
00:41:19,160 --> 00:41:27,080
But the founder and the CEO was brought on and only had 2% of equity and they were going to

441
00:41:27,080 --> 00:41:31,960
be diluted across further rounds because this is a seed at a 10 million valuation raise.

442
00:41:33,720 --> 00:41:41,720
What is your first impression on that? And how much do you bank on founder or CEO equity?

443
00:41:41,720 --> 00:41:51,480
And how little is too low at a seed stage? I mean, it really depends. Let me flip that

444
00:41:51,480 --> 00:41:57,640
question around. To me, it doesn't matter how much equity you own in the beginning,

445
00:41:59,080 --> 00:42:04,040
because like you said, that will be diluted over time. For me, what's more important is how

446
00:42:04,040 --> 00:42:11,720
comfortable are you with the inevitable dilution that will occur? If you tell me I want to own

447
00:42:11,720 --> 00:42:17,960
60% when this company sells, that's a non-starter for me because I assume that this company will

448
00:42:17,960 --> 00:42:25,640
need over 100 million in order to get to that stage, two, three rounds, multiple valuation

449
00:42:25,640 --> 00:42:30,360
bombs over time. You'll probably end up owning whatever the ownership is. It's hard to tell.

450
00:42:30,360 --> 00:42:37,000
So I don't really care about what you own at the beginning. What I care more about is,

451
00:42:37,000 --> 00:42:46,760
are you willing to, are you accepting the dilution? One, more importantly, do you have protections

452
00:42:46,760 --> 00:42:50,760
that you have embedded in the term sheet that make sure that you have a veto on around the

453
00:42:50,760 --> 00:42:55,560
financing or something like that? As in you're so hell bent on that ownership that you will block

454
00:42:55,560 --> 00:43:00,680
anything in order to maintain that ownership. That's a non-starter. So that's how I'd answer

455
00:43:00,680 --> 00:43:06,680
that piece of the question. The CEO question, people need to get paid what they're worth.

456
00:43:08,120 --> 00:43:14,360
And if the CEO thinks she or he is only worth that 2% equity and they're still willing to do it,

457
00:43:14,360 --> 00:43:25,080
okay, that's fine. What will happen eventually is that CEO, if they are smart enough, will look at

458
00:43:25,080 --> 00:43:31,880
coms over time and will realize that they are underpaid and will ask to be made whole or equal.

459
00:43:32,920 --> 00:43:38,040
And if they are good enough to be worth it, if the board thinks that the other investors

460
00:43:38,040 --> 00:43:42,280
think that they're worth it, it'll happen. They'll get that equity and they'll be happy.

461
00:43:42,280 --> 00:43:45,800
If the board or the management or whatever things they're not worth it, they will leave

462
00:43:45,800 --> 00:43:50,200
and a new CEO will be brought in and that new CEO will get whatever market comes up.

463
00:43:50,200 --> 00:43:56,040
So the market never lies. And in the end, compensation for management will always be

464
00:43:56,040 --> 00:44:02,920
similar to or closer to what the market can bear. And I say that because when I started

465
00:44:02,920 --> 00:44:10,920
one of my companies, we were hiring a head of R&D. And I looked at the market comp for Canada,

466
00:44:10,920 --> 00:44:16,840
for this person's role. And it was, I'm not going to say numbers, but it was a certain value.

467
00:44:16,840 --> 00:44:21,240
And when I told this person that value, they effectively said, yeah, that's nowhere close

468
00:44:21,240 --> 00:44:24,600
to what I'm making right now. Because they were looking at the market comp in the US,

469
00:44:24,600 --> 00:44:29,720
which was double what I was offering. So I'm like, okay, do I take a hit of two,

470
00:44:29,720 --> 00:44:35,400
three months of my runway in order to pay this person? Or is this person worth it? Because they

471
00:44:35,400 --> 00:44:39,160
will get me the two, three months of runway because they're better and more efficient.

472
00:44:39,160 --> 00:44:46,040
I ended up paying this person the US market comp and it's been amazing decision ever since.

473
00:44:46,040 --> 00:44:51,640
So no way of saying the market comp is the market comp and if management will get that eventually.

474
00:44:52,680 --> 00:44:59,960
Okay. Let's go deeper on that. Oftentimes, and maybe it's not often, but at times you will see

475
00:44:59,960 --> 00:45:05,880
the people who started the company are not the people who will scale it. Initially,

476
00:45:05,880 --> 00:45:11,000
commitment to the idea is critical as you have to be scrappy, you have to figure things out.

477
00:45:11,000 --> 00:45:16,360
But as you grow and there's a clearer vision, you want to bring in industry experts or people

478
00:45:16,360 --> 00:45:21,800
who have done it before. Or in some words, people say private equity people almost.

479
00:45:23,240 --> 00:45:28,600
When do you have that decision or that talk with the initial team that you might need to be replaced

480
00:45:28,600 --> 00:45:34,280
as the company grows? Do you have it at the first meeting when you meet them or do you have it later

481
00:45:34,280 --> 00:45:43,400
on? And just talk me through about that scenario. Yeah. I mean, management is usually smart enough

482
00:45:43,400 --> 00:45:47,960
to realize what they know and what they don't know. And when that transition happens,

483
00:45:47,960 --> 00:45:52,360
management will also tell you they can figure it out. But I think pretty quickly they realize that

484
00:45:52,360 --> 00:45:59,480
it's not going to happen or that they are not the best suited person for that. If it's the former,

485
00:45:59,480 --> 00:46:05,640
it tends to be a more friendly handover. If it's the latter, then it tends to be a bit more

486
00:46:05,640 --> 00:46:12,920
painful handover. But I think when we invest in people who are also backing these technologies,

487
00:46:13,720 --> 00:46:19,880
we tend to invest in people that have experience, that understand why, what, when, and therefore

488
00:46:19,880 --> 00:46:23,240
it's not been that painful of a discussion to have. And sometimes they bring it up themselves.

489
00:46:23,240 --> 00:46:28,680
Like, look, my passion lies in early stage stuff. I have zero interest in doing commercialization.

490
00:46:28,680 --> 00:46:33,000
So I have it over to somebody else. I still have my equity. I still have my calm, blah, blah, blah.

491
00:46:33,000 --> 00:46:38,760
And I can go back to doing that. So it's come up rarely, but when it does, it's not tend to be a

492
00:46:38,760 --> 00:46:44,440
pretty painful experience. It happened once where we had to let a CEO go because they didn't get that

493
00:46:45,080 --> 00:46:51,960
message. But that company had a whole other host of issues. That's a whole other long story.

494
00:46:52,600 --> 00:46:57,800
Yeah. It's good to hear that it's happened rarely. The last recession saw the birth

495
00:46:57,800 --> 00:47:05,080
of multiple unicorns, Slack, Uber, WhatsApp, Square, Airbnb, Dropbox, Fitbit. How has your

496
00:47:05,080 --> 00:47:09,720
investment strategy changed given the quote unquote looming recession?

497
00:47:13,080 --> 00:47:20,040
So we tended to, well, let's take it step back. Biotech, if you look at the Nasdaq stock index,

498
00:47:20,040 --> 00:47:27,400
it has been extremely volatile. And so there's a pretty bear market for biotech right now.

499
00:47:28,120 --> 00:47:33,000
There's been a bear market. There was a bull market for the last two years. There was also a

500
00:47:33,000 --> 00:47:36,840
bear market in the early 2020 during COVID when no one knew what was going to happen.

501
00:47:38,200 --> 00:47:47,880
What we did then was, and something we probably continue now, is back science for the sake of

502
00:47:47,880 --> 00:47:55,000
science and for the sake of making a difference in patients' life. And that science, that technology,

503
00:47:55,000 --> 00:47:59,240
it doesn't care about the recession. People are still getting sick. People are still getting

504
00:47:59,240 --> 00:48:03,400
hurt. People are still getting diseases. And the recession is not going to change that. I'm not

505
00:48:03,400 --> 00:48:08,440
talking about the financing and the insurance market. That's a whole other bull game. And they're

506
00:48:08,440 --> 00:48:16,120
always looking for new therapies. And our current war chest of therapies is good, but it's not great.

507
00:48:16,120 --> 00:48:21,480
And so if you are continuing to, and what we believe in is if you're continuing to invest in

508
00:48:21,480 --> 00:48:26,680
companies that are advancing biotech, that will make a difference in patients' life. And I talked

509
00:48:26,680 --> 00:48:30,520
about that through either clinical trials or through preclinical studies, whatever it is,

510
00:48:30,520 --> 00:48:35,960
then those will continue to be successful in the long run, because pharma is always looking to buy

511
00:48:35,960 --> 00:48:39,720
them. Patients are always looking for them. And VCs have so much drive power that they're looking

512
00:48:39,720 --> 00:48:43,720
to invest in them. So that's still a continuation of our thesis. We look for biology and start from

513
00:48:43,720 --> 00:48:50,040
there. And recession or no recession, that doesn't really change our mindset in terms of what we look

514
00:48:50,040 --> 00:48:59,640
at. From a company level, it's a little different. In the past, we might have spent a bit more in

515
00:48:59,640 --> 00:49:05,400
order to get some data or hire somebody because speed was of the essence, whereas now cash is of

516
00:49:05,400 --> 00:49:09,640
the essence. So we try to give them that extra few months of runway in case something goes wrong,

517
00:49:09,640 --> 00:49:13,000
or in case they need additional data to prove that or raise an extra amount of financing.

518
00:49:13,000 --> 00:49:15,320
So that's the mindset more than what we invest in.

519
00:49:17,560 --> 00:49:25,000
Okay. Let's go deeper into biotech. What in biotech are you most excited about? And then I

520
00:49:25,000 --> 00:49:32,840
have a few questions about timeline with that investment philosophy in mind, because inherently

521
00:49:32,840 --> 00:49:39,320
or intuitively, I'm finding that it may not fit the traditional venture return time scale.

522
00:49:39,320 --> 00:49:43,560
But let's initially talk about what you're more excited about and what are you most excited about

523
00:49:43,560 --> 00:49:54,600
in biotech? Yeah. Biotech, again, I'm biased. I'm in the sector, but biotech has had a

524
00:49:55,560 --> 00:50:01,560
renaissance in terms of discoveries over the last five to 10 years as technologies have improved

525
00:50:01,560 --> 00:50:06,920
and allowed us to really understand biology from a very granular perspective.

526
00:50:06,920 --> 00:50:11,400
And I don't talk about technologies to understand biology, but also technologies to process biology,

527
00:50:11,400 --> 00:50:17,400
stuff like computational biology, AI, et cetera, et cetera. So what we're seeing now are better

528
00:50:17,400 --> 00:50:23,240
tools to go deeper and deeper into understanding what makes cell stick, process stick, protein stick,

529
00:50:23,240 --> 00:50:30,120
et cetera, but also to do it at a scale where you don't have me or another PhD or another scientist

530
00:50:30,120 --> 00:50:35,560
trying to say, oh, I'm trying to figure that out. You let AI go and figure it out and spit out what

531
00:50:35,560 --> 00:50:40,120
you think the pathway is. So that confluence has started to really come by. And for me, that is

532
00:50:40,120 --> 00:50:46,200
really exciting. The ability to go really, really granular into a cell specific level or even into a

533
00:50:46,200 --> 00:50:52,840
DNA specific, RNA specific. So what's happening in this disease with this RNA splicing as an example.

534
00:50:53,800 --> 00:50:58,920
And then understanding that in terms of its disease causing capabilities, and then also

535
00:50:58,920 --> 00:51:03,880
processing that level of information from an AI perspective in order to say this gene is in

536
00:51:03,880 --> 00:51:10,360
order to say this gene is involved or these cells are involved in healthy versus non-healthy.

537
00:51:11,240 --> 00:51:18,520
And then using AI, using other capabilities to develop diagnostics in order to better select

538
00:51:18,520 --> 00:51:24,840
those patients in order to enhance their chance of success, precision medicine at an overall level.

539
00:51:25,400 --> 00:51:30,920
That's what gets me excited. I think, if you look at the history of biotech or history of biology

540
00:51:30,920 --> 00:51:38,120
and therapeutics, it was a whole body. Your leg is broken. Let's fix your leg. And there's

541
00:51:38,120 --> 00:51:45,720
miasmas that we can solve. Going to an organ specific, you have a heart disease, you have a

542
00:51:45,720 --> 00:51:51,640
lung disease, you have a kidney disease. Going to tissue, this part of your lung is affected. This

543
00:51:51,640 --> 00:51:57,320
part of your heart is affected. Going even deeper now to the cell level and saying your cells here

544
00:51:57,320 --> 00:52:03,960
are affected. So you have single cell genomics where you can say this subset of cells within the

545
00:52:03,960 --> 00:52:09,000
tissue, within the organ, within the body is affected and is driving the disease. And then

546
00:52:09,000 --> 00:52:13,080
going even deeper down that level. This DNA fragment is different from that and therefore

547
00:52:13,080 --> 00:52:18,760
driving that home. That gets me excited. When I was graduating undergrad, I guess when you

548
00:52:18,760 --> 00:52:24,360
were graduating undergrad as well, in 2008, translational medicine was all the rage.

549
00:52:24,360 --> 00:52:30,600
So exactly what you're saying, how that translates to clinical practice. In clinical practice,

550
00:52:30,600 --> 00:52:36,840
there isn't much precision medicine from what I've seen in my clinical practice. The antibiotics

551
00:52:36,840 --> 00:52:42,440
we use are broad. We throw steroids at everything and everyone feels good in steroids and it's not

552
00:52:42,440 --> 00:52:51,960
targeted at all. What has happened in the past 15 years that that hasn't translated into clinical

553
00:52:51,960 --> 00:52:59,880
practice? And what do you think needs to happen differently over the next 20 years to have that

554
00:52:59,880 --> 00:53:06,200
precision medicine? Now it has happened a bit in cancer. Now with immunotherapy, it's happening a

555
00:53:06,200 --> 00:53:11,240
bit more, but it really hasn't panned out and we're still using the same penicillin and steroids

556
00:53:11,240 --> 00:53:20,760
that we used 50 years ago. So it boils down to, this is a broadly capitalist society.

557
00:53:20,760 --> 00:53:26,520
And what gets paid is, what gets advanced is what gets paid, right? Effectively. And who's willing

558
00:53:26,520 --> 00:53:31,320
to buy something at the other end and who's willing to fund it in order to get it to a stage

559
00:53:31,320 --> 00:53:39,240
where you can buy it at the other end. Cancer, rare diseases, all of that. There are a lot of,

560
00:53:39,720 --> 00:53:48,680
it's more, what's the word, something like cancer. It's painful. It's really hard. And it's also got

561
00:53:48,680 --> 00:53:54,040
a lot of sort of attention towards it, right? Versus something like heart disease, kidney disease,

562
00:53:54,040 --> 00:53:58,440
all of that. I mean, you're a doctor and I can ask you so many questions about this because I'd love

563
00:53:58,440 --> 00:54:03,560
to learn, but the biggest killer of people is heart disease. It's not cancer, right? But the

564
00:54:03,560 --> 00:54:11,400
dollars going towards cancer is significantly higher than heart disease. And so what's effectively

565
00:54:11,400 --> 00:54:15,800
happened over the last five, six years, and we're starting to see that now is cancer, precision

566
00:54:15,800 --> 00:54:23,880
medicine approaches are abound. You can go after, if you have an MMR plus disease, you can get this

567
00:54:23,880 --> 00:54:29,800
therapy. And if you have MMR negative, you can get this. So it's really sort of driven by precision

568
00:54:29,800 --> 00:54:36,920
medicine. And that's primarily because of dollars going into that sector. Like VCs, pharma is buying

569
00:54:36,920 --> 00:54:43,240
cancer therapies at a much higher rate than cardio and some of these other indications. VCs are

570
00:54:43,240 --> 00:54:48,760
therefore saying, I need to make a return. So I'm going to fund cancer because it generates a higher

571
00:54:48,760 --> 00:54:54,920
return than cardio and the trials are shorter for cancer versus cardio, et cetera, et cetera. And so

572
00:54:54,920 --> 00:54:59,240
there's more interest going towards that. My broader thesis and at least what I'm hoping for

573
00:54:59,240 --> 00:55:05,240
and what I'm trying to drive is at some point you can only do so much in cancer because you've got

574
00:55:05,240 --> 00:55:09,960
into that 80%, right? And how much more dollars do you want to spend to go from 80 to 100? Because

575
00:55:09,960 --> 00:55:15,960
how much are you solving? Do you really need a 10th line of therapy when four or five lines is

576
00:55:15,960 --> 00:55:23,080
enough? And at some point the patients themselves are saying enough, but I'm not. So I'm hoping that

577
00:55:23,080 --> 00:55:28,760
this precision approach that's now been tested and validated with oncology applies to some of the

578
00:55:28,760 --> 00:55:34,040
other indications like cardio and neurology and stuff like that. And that's what I'm trying to

579
00:55:34,040 --> 00:55:39,400
drive. I'm trying to say, if I start a company, can I look at a cardio based approach to

580
00:55:39,400 --> 00:55:45,480
infectious diseases? Can I look at a cardio based approach, a precision based approach to auto

581
00:55:45,480 --> 00:55:49,960
immune conditions, to neurology and to drive that forward? That's what I'm trying to do. Can we

582
00:55:49,960 --> 00:55:57,000
learn from that and apply it to somewhere else? Yeah, this is an interesting question and

583
00:55:57,000 --> 00:56:00,760
surprisingly I haven't thought much about it. So I'm going to think kind of on the fly here.

584
00:56:00,760 --> 00:56:11,560
I think part of it is cancer is such a scary diagnosis and it usually is indolent for a long

585
00:56:11,560 --> 00:56:14,600
time where you don't have symptoms for a long time and then you have them and then you know

586
00:56:15,960 --> 00:56:20,680
you have cancer and then it's an urgency. There's a sense of urgency with cancer that there isn't

587
00:56:20,680 --> 00:56:26,840
with diabetes and high blood pressure, which are the drivers of heart disease 10, 20 down the line.

588
00:56:26,840 --> 00:56:37,720
The other answer I would give is the treatment for heart disease and diabetes quite a bit as diet and

589
00:56:37,720 --> 00:56:42,840
exercise, which people don't like to hear and there's not much money to be made in terms of

590
00:56:43,640 --> 00:56:48,840
this is this one novel diet we can develop through research and clinical trials. We know the

591
00:56:48,840 --> 00:56:54,120
Mediterranean diet is the best diet from a clinical perspective and exercise, go for walks,

592
00:56:54,120 --> 00:57:01,400
exercise. There's not much there in terms of from a capital perspective, but cancer, there is no diet

593
00:57:01,400 --> 00:57:08,120
and exercise that's been proven so far to be effective for cancer treatment and therefore

594
00:57:08,120 --> 00:57:14,760
rely on drugs. I think that sense of urgency, if you go through the marketing principles and

595
00:57:15,480 --> 00:57:19,640
again I might butcher this by Robert Kaldini, he wrote this book, Influence Persuasion. He's

596
00:57:19,640 --> 00:57:24,680
kind of the guru of marketing. He talks about scarcity, urgency, social proof,

597
00:57:25,960 --> 00:57:31,240
there's five of them, I'm forgetting the other two, but they apply to cancer, they don't apply

598
00:57:31,240 --> 00:57:38,840
to heart disease. There is no sense of urgency. There aren't people suffering from diabetes and

599
00:57:39,720 --> 00:57:46,920
physically it's not the same way, you're not shaving your head. A lot of biases against diabetes

600
00:57:46,920 --> 00:57:53,960
affects the low SES population more significantly. I think that creates a bias towards who gets

601
00:57:53,960 --> 00:57:58,840
diabetes, who suffers from it, which is not fair and I see this in my patient population a lot,

602
00:57:59,640 --> 00:58:06,280
but from a purely evil capitalist perspective, they don't have good insurance, they're not going

603
00:58:06,280 --> 00:58:09,560
to pay hundreds of thousands of dollars for treatment, so why put money in there?

604
00:58:09,560 --> 00:58:16,040
It would be amazing to have therapies for heart disease, heart failure, hypertension, diabetes

605
00:58:16,040 --> 00:58:22,680
that are more targeted. The ones we have right now, they are dealing with the end results and

606
00:58:22,680 --> 00:58:29,240
most of them are, they're focusing on symptom management and preventing disease or progression,

607
00:58:29,240 --> 00:58:35,080
but they don't reverse the disease, almost none of them do because even the pathophysiology is

608
00:58:35,080 --> 00:58:41,400
so poorly understood that we don't know how and I think there's a gap here for precision medicine,

609
00:58:42,440 --> 00:58:48,360
but I don't know if just the principles of marketing allow for that gap to be filled

610
00:58:48,360 --> 00:58:54,120
without a shift in our mindset of what diabetes and heart disease is and how much it actually

611
00:58:55,400 --> 00:58:57,560
damages our society and ourselves.

612
00:58:57,560 --> 00:59:06,120
Yeah, I think it boils down to incentives as well. The heyday for diabetes and cardio research

613
00:59:07,320 --> 00:59:12,360
was the, I'm probably going to say this wrong, but let's say the 80s and 90s when Lipitor and

614
00:59:12,360 --> 00:59:18,200
Metformin and all of these came out and when they first came out, they were priced quite high.

615
00:59:18,200 --> 00:59:21,480
I mean, I have no idea what Lipitor was and all of these other

616
00:59:21,480 --> 00:59:30,120
what's the class? The statins. There was a lot of money that went to them. They had a lot of benefit

617
00:59:30,120 --> 00:59:38,440
and the low hanging fruit of the disease was broadly treated with that and people just assumed

618
00:59:38,440 --> 00:59:45,000
that should be enough and now do we really want to do that? And I think that's the biggest

619
00:59:45,000 --> 00:59:51,800
problem. We really want to run a 10 year, five year, three year clinical trial where we think

620
00:59:51,800 --> 00:59:56,760
the outcome is going to work or not. It's difficult. The same issue with vaccines. The same issue with

621
00:59:56,760 --> 01:00:04,360
antibiotics. Whereas precision medicine, because by nature it's fewer patients, you can charge more

622
01:00:04,360 --> 01:00:10,600
per patient, but it's not going to be enough. It's not going to be enough. It's not going to be enough.

623
01:00:10,600 --> 01:00:16,520
So precision medicine, because by nature it's fewer patients, you can charge more per patient and you have a good sense of

624
01:00:16,520 --> 01:00:22,440
if this is positive, I can sell this. I can raise money. I can do X, I can do Y. It's driven the market towards that.

625
01:00:23,640 --> 01:00:34,600
Now at some point, a majority of the small molecules and even some antibodies that came out in the 90s, the 2000s, the 2010s will go generic.

626
01:00:34,600 --> 01:00:44,120
And they should go generic. And I'm hoping that the wave that you saw in the 90s and early 2000s with the Avastans and the

627
01:00:44,120 --> 01:00:51,080
statins is what you will see with the precision cancer approaches and the precision other approaches that exist right now

628
01:00:51,080 --> 01:00:58,760
that are high priced. And then eventually the field will move towards changing other things. Now what we are seeing is we are starting to see some

629
01:00:58,760 --> 01:01:06,040
precision approaches in diabetes, some precision approaches in cardio. The problem is that I talk to doctors about this all the time.

630
01:01:06,040 --> 01:01:16,840
Like, look, if I'm creating an antibody against PCSK9, which is now approved, who will you give it to?

631
01:01:16,840 --> 01:01:22,600
And every single doctor has said, I will only give it to X percent of my patients because statins work so well.

632
01:01:22,600 --> 01:01:26,600
And if statin one doesn't work, I'll give statin two. If statin two doesn't work, I'll give statin three.

633
01:01:26,600 --> 01:01:37,000
Or I'll give combos of statins and really try to drive that forward. And so for me, I have to deploy my capital and I have to return money for my investors.

634
01:01:37,000 --> 01:01:49,720
So why would I try to do a drug that's competing for such a low value of patients, such a low number of patients, but also I can't charge as much as I can in order to maximize what I can during the patent life.

635
01:01:49,720 --> 01:02:12,920
So that's part of the miscued incentives that exist. There's a book by RA Capital founder, blanking on his name now, but it's called The Great American Drug Tool that talks a lot about what we as an industry need to do because we are working in innovation.

636
01:02:12,920 --> 01:02:24,200
What the market needs to understand in terms of the price that comes in for that innovation, in terms of the nine failures for the one success and what the government needs to understand in order to pay for that.

637
01:02:24,200 --> 01:02:39,320
So it's a way too complicated system that we can't really solve now. But I'm hoping that even if those problems don't get solved, the learnings tend to be more universal.

638
01:02:39,320 --> 01:02:48,200
And those learnings apply to other indications that allows us to get better treatments for patients that actually make a difference.

639
01:02:48,200 --> 01:02:55,560
Because I'm sure you're telling me statins work in 60% of the patients, but 40% of the patients have no benefit from throwing a number out there.

640
01:02:55,560 --> 01:03:03,240
So how can we solve those 40% of the patients? How can we solve the 20% of the patients that don't work with current therapies? And I'm hoping that eventually we'll get to that stage.

641
01:03:03,240 --> 01:03:20,600
You know, like for better or worse, there's just been such a focus on diet and exercise for heart disease and diabetes that, and this is from both physicians and patients, that we're moving away because most patients, you know, they don't want to be on medications.

642
01:03:20,600 --> 01:03:25,800
For cancer, there's just an acceptance that you have to have medication, radiation surgery.

643
01:03:25,800 --> 01:03:36,520
Because it's usually for a short period, right? Like apart from some leukemias and lymphomas, like you have medication for six months to a year, and then you're done, you're in remission, you get monitoring.

644
01:03:36,520 --> 01:03:45,400
Diabetes and heart disease isn't like that. If you're diagnosed at 30, you are on medication forever. So the goal is always to get off medication.

645
01:03:45,400 --> 01:03:52,680
And I don't know if that lines well with creating drugs, if the goal is to get off them.

646
01:03:52,680 --> 01:04:01,160
And maybe it does with a higher price. And if they are, if it's precision medicine, it's actually reversing the disease.

647
01:04:01,160 --> 01:04:13,400
And I think we need to learn more about hypertension and how, like right now we have what we call the Virgo's triad, which is there are three things that lead to plaque formation.

648
01:04:13,400 --> 01:04:26,600
It's hypercoagulability, so genetic states like factor V, I'm losing every listener right now. Endothelial injury, which is turbulent blood flow from hypertension and stasis, or blood is not flowing well,

649
01:04:26,600 --> 01:04:33,720
which happens in irregular heartbeat or atrial fibrillation or heart failure because your ventricle expands as well.

650
01:04:33,720 --> 01:04:51,320
We don't know more than that. And that is not a molecular explanation, right? That's not a cellular explanation. That's just these three things can cause plaques, which can lead to heart attacks, which can lead to arrhythmias, heart failure, lots of different things.

651
01:04:51,320 --> 01:04:57,560
In cancer, there's just a lot more research in understanding the genetic and the molecular pathway.

652
01:04:57,560 --> 01:05:06,440
And I know those are two different things, but I just, I don't see that from my perspective in cardiology and diabetes. And I would love for you to correct me.

653
01:05:06,440 --> 01:05:17,640
Where is the molecular research in that? And will we move to a better understanding of why these diseases happen so we can reverse them with precision medicine?

654
01:05:17,640 --> 01:05:33,880
Maybe PSK9 inhibitors is a good example. Primary hyperlipidemia or primary elevated cholesterol, we don't treat anymore unless the exception would be your triglycerides are 10, which is very high, and you risk a pancreatitis, but that's a separate conversation.

655
01:05:33,880 --> 01:05:39,240
I'm going to stop because I'm just going to lose everyone the deeper I go into the science of this.

656
01:05:39,240 --> 01:05:50,280
But give me your understanding, and I'd love for you to challenge me. Is it more research being done or is it being done and I just don't know about it in the path of physiology behind them?

657
01:05:50,280 --> 01:06:01,240
Yeah, I mean, cardiology, PCSK9 is a good example. There's a number of, was it, I'm going to butcher it. I think it's ETFR or EGF, no, not EGF.

658
01:06:01,240 --> 01:06:13,800
There was, so PCSK9 and another genetic component to cardiac disease was studied at the same time. PCSK9 won, this one didn't really work out and then failed. And this was about 10 years ago.

659
01:06:13,800 --> 01:06:24,600
Obesity, there's a lot of work going into obesity. But I mean, I think you know this better than me, obesity is not one disease, it's multiple disease.

660
01:06:24,600 --> 01:06:42,520
It's symptom is common, but the path of physiology is different. And you probably, I'm sure, gotten a lot of requests from people asking for that anti-obesity drug on label as well as off label.

661
01:06:42,520 --> 01:06:51,480
So there is some work going into that. And then diabetes as well. I think, you know, you can't give one medicine and fix diabetes.

662
01:06:51,480 --> 01:07:05,880
I think diabetes tends to be a little bit more complex, but it's also more approachable. So we have looked at a number of companies that are creating 3D organoids for diabetes or 3D pancreas as a 3DX and 3DY in order to produce insulin and do that.

663
01:07:05,880 --> 01:07:18,120
So there is some work going there. I think the issue and the reason, you know, if someone comes to me and says, you know, I'm starting a, I'm starting, I've identified this genetic mutation for cardiology.

664
01:07:18,120 --> 01:07:31,560
Give me money. My first question is, what's the clinical trial plan? And if you tell me my clinical trial is five years and it needs 10,000 patients, I'm trying to calculate, okay, so that's a $50 million trial.

665
01:07:31,560 --> 01:07:41,320
So do I really want to deploy my money for five years where the outcome could be a yes or no?

666
01:07:41,320 --> 01:07:50,680
Whereas in cancer, I know because in a phase one trial, I will get some semblance of tissue cancer reduction.

667
01:07:50,680 --> 01:08:00,760
Patients will start feeling better, blah, blah, blah. So I can see positive outcomes immediately. And therefore I can raise additional capital on that. I can sell it to somebody. I can do that.

668
01:08:00,760 --> 01:08:13,560
So if you were to take a complete step back, one of the biggest criticisms about public companies and going public is that you're very hell bent upon your quarterly reports and making sure you hit that.

669
01:08:13,560 --> 01:08:27,400
Diseases have started to have a similar outcome as well. What is the fastest way I can get a data point that I can then go out and raise additional capital, additional, you know, a transaction around?

670
01:08:27,400 --> 01:08:35,560
Because that's the currency for the VC. It's currency for pharma. And the patient is a part of that process, but it's not a core component of the process.

671
01:08:35,560 --> 01:08:45,160
Now in cardiology, if someone has to come and tell me, look, I have discovered this gene. I know that if I modulate that gene, I will have this endpoint.

672
01:08:45,160 --> 01:08:54,920
I can study this endpoint. And I know that, you know, the FDA tells me that this endpoint is sufficient to get the phase two whole, the whole process.

673
01:08:54,920 --> 01:09:01,720
That gets me excited because I know that there's a short term outcome for my dollars, but I'm willing to lose it all.

674
01:09:01,720 --> 01:09:07,400
But I don't want to wait for five years to know if I've lost it or kept it. I want to wait a year in order to see that.

675
01:09:07,400 --> 01:09:18,880
And there's a couple of companies. So there's World Therapeutics in Boston. There's a couple of other gene therapy companies looking at cardiology and sort of precision cardiology in order to figure out whether it works or not.

676
01:09:18,880 --> 01:09:29,200
We have a portfolio company that's looking at long QT syndrome and sort of the driver, the genetic drivers behind that in order to see if you can modulate that and get an outcome one way or the other.

677
01:09:29,200 --> 01:09:37,520
So there is that still there is a lot of work going into that, but it's not in the umbrella of cardiology or umbrella of diabetes.

678
01:09:37,520 --> 01:09:44,400
It's in small subsets because the best way to what is that phrase? The best way to eat a pie is to cut into small pieces.

679
01:09:44,400 --> 01:09:53,200
And that's what we're trying to do. That goes back to what I said, the precision approach. You're trying to get smaller fragments and solve for that versus getting the bigger picture.

680
01:09:53,200 --> 01:10:05,840
Yeah, I think long QT syndrome is something that is worth fixing. There's a lot of medications we use, anti-nausea medications, mental health medications, methanol that prolong it more.

681
01:10:05,840 --> 01:10:11,440
And it's a problem. So I think something to fix that would be a great part.

682
01:10:11,440 --> 01:10:21,320
I mean, that conversation is exactly what we have with academics. Look, before we made the investment, we talked to 10 cardiologists, 20 cardiologists, like, tell me about your process.

683
01:10:21,320 --> 01:10:28,040
How are you treating these patients? Right. So that goes back to about when we started on what we see.

684
01:10:28,040 --> 01:10:35,760
How do you do diligence? If you were to do 100 percent of your work, you would talk to a thousand cardiologists or a hundred cardiologists.

685
01:10:35,760 --> 01:10:42,760
Stupid. You talk to 10. At some point, the answer is repetitive. But for me, it was, OK, how do you understand the pathway for patient treatment?

686
01:10:42,760 --> 01:10:48,080
So what's the diagnosis process? How many are diagnosed? How many failures? What's the treatment?

687
01:10:48,080 --> 01:10:52,400
So if you had told me, listen, I think you said methadone, but I could be wrong.

688
01:10:52,400 --> 01:10:56,560
They said methadone works in 95 percent of the patients and we never have a problem with that.

689
01:10:56,560 --> 01:11:04,160
I'm like, OK, so 5 percent of the patients, is it worth me investing 100 million or raising 100 million or others to solve that problem?

690
01:11:04,160 --> 01:11:08,920
Unlikely. It solves for 30 percent of the patients. And, OK, you can figure out what's the right fragment.

691
01:11:08,920 --> 01:11:15,160
How do you price that and how do you. No, I so methadone makes it longer, makes it worse.

692
01:11:15,160 --> 01:11:18,560
The only treatment we have is magnesium and it's temporary.

693
01:11:18,560 --> 01:11:22,640
But let's go back to investing before everyone leaves.

694
01:11:22,640 --> 01:11:26,720
Tailwinds drive a considerable amount of success.

695
01:11:26,720 --> 01:11:32,280
Do you agree or disagree with that? And what early tailwinds are you banking on right now?

696
01:11:32,280 --> 01:11:40,960
And another way to answer this question is what emerging markets do you think are growing that are good to invest in startups in right now?

697
01:11:40,960 --> 01:11:51,360
Emerging markets in the market definition or emerging markets in the science and the science definition and also what tailwinds.

698
01:11:51,360 --> 01:11:56,040
So a couple of tailwinds like COVID would be a tailwind. Obviously, it's impossible to predict that.

699
01:11:56,040 --> 01:12:08,280
But what are some you're predicting or work from home would be possible to predicting right now or education moving away from knowledge base to application based?

700
01:12:08,280 --> 01:12:17,320
So. One of the one of the tailwinds, I don't know if it's a real one, I'll just talk about how I think about this.

701
01:12:17,320 --> 01:12:26,760
One of the things that I saw a couple of years ago was that everyone's talking about AI and everyone's talking about figuring out what cats look like.

702
01:12:26,760 --> 01:12:34,440
Sure, that's important, but. Could you use it in other areas?

703
01:12:34,440 --> 01:12:36,640
There were a lot of not the first person I think about this.

704
01:12:36,640 --> 01:12:38,800
There was a lot of AI interest in biology.

705
01:12:38,800 --> 01:12:48,120
But for me, the question was, OK, how important is AI in biology and how important how important will it continue to be before it becomes a commodity?

706
01:12:48,120 --> 01:12:53,160
So there's a small window where new technology is really new technology before it becomes a commodity.

707
01:12:53,160 --> 01:12:58,640
How long is that space and how do you invest in that as quickly as possible in order to come to that table?

708
01:12:58,640 --> 01:13:04,120
And so I led our team's investment in deep genomics out of Toronto.

709
01:13:04,120 --> 01:13:09,200
I led our team's investment in a company called Celsius out of out of Boston.

710
01:13:09,200 --> 01:13:13,280
And both of them are, you know.

711
01:13:13,280 --> 01:13:20,520
Biology companies that use AI to process data and do X, right, in the case of deep genomics,

712
01:13:20,520 --> 01:13:30,200
it's identify steric blocking oligos against rare diseases and Celsius's case, it's looking at single cell genomics in order to understand

713
01:13:30,200 --> 01:13:38,440
how one set of patients reacts to therapy or does not react to therapy versus other in order to find that genetic component to disease and vice versa.

714
01:13:38,440 --> 01:13:49,040
I continue to think that that would become that that will that will that will stay an AI enabled biology will become a core component of biology.

715
01:13:49,040 --> 01:13:52,640
But I think we're already getting into the point where it's starting to become commoditized.

716
01:13:52,640 --> 01:13:56,360
Every company will use some form of AI or the other in order to drive that forward.

717
01:13:56,360 --> 01:14:00,320
That's one that we still we still got that window before it started to become commoditized.

718
01:14:00,320 --> 01:14:06,160
So that's something that we're looking at in great detail and going into more and more subsets.

719
01:14:06,160 --> 01:14:16,880
The other one that I think will become really cool and we talked about a little bit is, you know, there is you there is nothing new in the world.

720
01:14:16,880 --> 01:14:22,440
There is only stuff that can be discovered and used in a different area.

721
01:14:22,440 --> 01:14:30,600
And that could be new by definition, but if you look at it, it probably has a history of how it is developed and how it is how to identify.

722
01:14:30,600 --> 01:14:34,560
And so for me, that applies to oncology and neurology, like we talked about.

723
01:14:34,560 --> 01:14:38,200
I think that we will be moving towards more precision based approaches in neurology.

724
01:14:38,200 --> 01:14:48,840
So we won't treat autism, which is an umbrella term, but we might treat some aspects of autism, some genetic drivers of autism in order to get to that, get to better treatment.

725
01:14:48,840 --> 01:15:00,040
And the best example of that is cystic fibrosis, huge gene, multiple mutations, vertex started off with five percent of the patients and now covers about 95 percent of the patients.

726
01:15:00,040 --> 01:15:04,360
So I think that's going to apply for neurology and going to apply for other other areas as well.

727
01:15:04,360 --> 01:15:15,040
The other one that I think could be really interesting, and I don't think we've even scratched the surface of that, is we talk a lot about genetic drivers of disease.

728
01:15:15,040 --> 01:15:21,040
And every single gene therapy at the moment is saying, I will go and change that one gene and it'll solve all problems.

729
01:15:21,040 --> 01:15:28,320
It's never going to work. So how can you develop combination gene therapies in order to drive that forward?

730
01:15:28,320 --> 01:15:34,520
To say to almost get to the C word, the cure word, right, there's still probably 15, 20 years out from there.

731
01:15:34,520 --> 01:15:42,560
But there are starting you're starting to see a lot of these trends towards CRISPR based approaches or gene editing based approaches that are starting to move in that direction.

732
01:15:42,560 --> 01:15:49,040
But we still know in these days. So again, it goes back to we're in that phase where it's new technology and it's exciting.

733
01:15:49,040 --> 01:15:53,520
And let's see if we can maximize that before it becomes a commodity.

734
01:15:53,520 --> 01:16:02,320
You know, it sounds like you're exciting, you're banking on the product or the technology itself and the market is almost secondary.

735
01:16:02,320 --> 01:16:08,920
And I might not be reading this right. In venture, the timeline is generally five to ten years.

736
01:16:08,920 --> 01:16:19,560
Is that your timeline as well in terms of returning capital? And how do you balance that with biotech, which the timeline might be 15 to 20 years at times?

737
01:16:19,560 --> 01:16:26,800
Yeah, so the good thing and the bad thing for therapeutics is the market exists.

738
01:16:26,800 --> 01:16:30,880
There are patients with that disease, you're not having to create a market of sorts.

739
01:16:30,880 --> 01:16:34,760
And so, I mean, it's still a core component of our diligence.

740
01:16:34,760 --> 01:16:39,960
Are we solving a disease that affects 10 people in the world, a thousand people or a hundred thousand people?

741
01:16:39,960 --> 01:16:43,440
That's a core component of our diligence. But the market exists.

742
01:16:43,440 --> 01:16:54,480
And so for us, it's a question of what is the proportion of market that is best suited for the technology and how do you solve that first before you can expand?

743
01:16:54,480 --> 01:16:58,240
So that's how I think of it. So it's not about the market doesn't exist. I don't care about it.

744
01:16:58,240 --> 01:17:04,960
Let me look at a technology, but let me look at this technology. How is it differentiated from the other technologies out there?

745
01:17:04,960 --> 01:17:10,880
And how is it truly solving the problem for X number of patients that have this disease?

746
01:17:10,880 --> 01:17:17,200
And then as a company expands or gets acquired or whatever happens, how do you scale that up?

747
01:17:17,200 --> 01:17:21,520
We've been in a bull market for the last four or five years, whether for good or bad.

748
01:17:21,520 --> 01:17:28,160
But a lot of companies have gone public with preclinical data or even earlier data.

749
01:17:28,160 --> 01:17:32,160
And there's going to be a culling of that over the next couple of years, for sure.

750
01:17:32,160 --> 01:17:43,320
But going back to timelines, we have the same, say, five years of investment, 10 years of 10 years to return the capital.

751
01:17:43,320 --> 01:17:52,080
So we tend to drive our companies to go public once the data is appropriate, when appropriate, when the market is ready for it.

752
01:17:52,080 --> 01:18:01,120
Because our job as money managers is to enable these companies to grow up and become self-sustaining in some capacity or the other.

753
01:18:01,120 --> 01:18:08,040
And that could be in either their biology works and it's got some validation, they've got capital and they've got a management team.

754
01:18:08,040 --> 01:18:14,480
And if you can solve those three problems and the company can go public, then they will need to raise additional capital from the markets.

755
01:18:14,480 --> 01:18:16,480
But they have the capacity to do that.

756
01:18:16,480 --> 01:18:22,760
And there are other investors that go and invest in that sector and we can hand it over to them and we can go back to what we enjoy doing,

757
01:18:22,760 --> 01:18:27,480
which is starting companies and investing them and getting them to the stage where they're ready.

758
01:18:27,480 --> 01:18:32,760
It often works out in the seven to 10 year time frame.

759
01:18:32,760 --> 01:18:36,320
That's what I hope it does for the past, it will continue to do for us.

760
01:18:36,320 --> 01:18:38,680
And so that's the place we play in.

761
01:18:38,680 --> 01:18:48,760
And I think the market is big enough that there are people in every sector and play in different areas that will continue to allow these companies to scale up and get products to patients.

762
01:18:48,760 --> 01:18:57,880
Yeah, again, this is another differentiator you have where most investors would want an acquisition and not to go public and deal with banks.

763
01:18:57,880 --> 01:19:13,280
How is that because you have just perfected a process of going public by not more M&A activity, which is what most investors from my knowledge go towards?

764
01:19:13,280 --> 01:19:17,560
Yeah, I mean, so it's not like we will say no to an M&A, right?

765
01:19:17,560 --> 01:19:19,280
The price has to be right.

766
01:19:19,280 --> 01:19:32,920
I think what we've seen and what we saw with the BDC fund and the current fund is if you are building a company to get it sold, then you are a hell bent on somebody else buying that company.

767
01:19:32,920 --> 01:19:37,400
So it's almost like you're putting the responsibility on someone else.

768
01:19:37,400 --> 01:19:40,600
And if that person or those people don't buy it, then what?

769
01:19:40,600 --> 01:19:41,960
You're screwed.

770
01:19:41,960 --> 01:19:52,600
Whereas if you can build a company to, I mean, it's like a kid, right, if you raise your kid to be a doctor only, and if they're not a doctor, what happens then?

771
01:19:52,600 --> 01:19:53,680
Right. Are you disappointed?

772
01:19:53,680 --> 01:19:55,280
Are you disowning them? What happens?

773
01:19:55,280 --> 01:19:56,800
Right. It's not going to happen.

774
01:19:56,800 --> 01:20:06,760
So you build resilience in the company when you build optionality and you say, look, we will enable you to get to a stage where you can go public.

775
01:20:06,760 --> 01:20:09,280
After that, you're on your own.

776
01:20:09,280 --> 01:20:12,280
If you choose to buy another company, go for it.

777
01:20:12,280 --> 01:20:13,800
If you choose to sell, go for it.

778
01:20:13,800 --> 01:20:15,120
If you choose to do X, go for it.

779
01:20:15,120 --> 01:20:16,480
It's really up to you.

780
01:20:16,480 --> 01:20:25,760
And what we have seen is that creating that optionality where the company can say, listen, M&A buyer, your offer is not good enough.

781
01:20:25,760 --> 01:20:35,400
So I'm going to go public tends to drive up the price because M&A buyers will say, yeah, you know what, actually, fine, I can pay more because you have optionality.

782
01:20:35,400 --> 01:20:36,840
And so that's how we think about it.

783
01:20:36,840 --> 01:20:42,960
Now, that also was a thinking when the markets were hot and any company could go public.

784
01:20:42,960 --> 01:20:45,440
That's obviously changed now.

785
01:20:45,440 --> 01:20:53,560
But I think the code is if you can build good technology, good management and good data, good things will happen.

786
01:20:53,560 --> 01:20:58,800
That's a very interesting take, but it makes complete sense.

787
01:20:58,800 --> 01:21:00,600
I'll ask you one last question.

788
01:21:00,600 --> 01:21:04,320
Ikigai is this Japanese concept of purpose for being.

789
01:21:04,320 --> 01:21:09,920
It's the intersection of what you love to do, what you're good at and what the world will pay you for.

790
01:21:09,920 --> 01:21:16,200
Have you found your Ikigai and what is the end goal for you personally, Bharat?

791
01:21:16,200 --> 01:21:21,920
That's way too philosophical a question.

792
01:21:21,920 --> 01:21:29,000
For me, it's, you know, well, since it's your last question, I'll loop it back to your first question.

793
01:21:29,000 --> 01:21:35,960
You said what drives you as a kid and what allows you to stay, be who you are and what have you pushed out?

794
01:21:35,960 --> 01:21:41,160
And I told you then curiosity was what I had as a kid and what I think continues to drive me.

795
01:21:41,160 --> 01:21:42,640
And that still that answer now.

796
01:21:42,640 --> 01:21:50,240
But for me, I won't say it's a love for learning because that's just too cheesy, but it's more a sense of I want to know how things work.

797
01:21:50,240 --> 01:21:52,760
I want to understand how, what, when, where, why.

798
01:21:52,760 --> 01:21:59,080
And so for me, what I enjoy doing is talking to smarter people, way more smarter people than I,

799
01:21:59,080 --> 01:22:06,760
and wondering what they're doing, why they're doing it and why they've dedicated so much of their life to do just that one thing and that one thing.

800
01:22:06,760 --> 01:22:11,760
And just by talking to them for me is exciting and energizing.

801
01:22:11,760 --> 01:22:19,800
And the positive outcome of that, because of the sector that I've chosen, is it benefits patients because you're developing new therapies.

802
01:22:19,800 --> 01:22:26,200
And so that's one positive. And then the other positive is the best way to do it.

803
01:22:26,200 --> 01:22:31,600
I don't have the 200 million dollars to go do it by myself. I need to raise it from other people.

804
01:22:31,600 --> 01:22:41,040
And so if I enable them to deploy that capital and generate a return for them, then that makes them happy because they have pensioners and all of that.

805
01:22:41,040 --> 01:22:49,400
They're paying that money out. So there's sort of that multitude of effects that come that I think can only be that for me personally can be done

806
01:22:49,400 --> 01:22:56,760
because I'm curious and I like learning about new stuff. And as long as I can keep doing that, I'll do it.

807
01:22:56,760 --> 01:23:03,000
Talking to smarter people is what I'm trying to do with this podcast. And I'm very lucky to have people like yourself join me.

808
01:23:03,000 --> 01:23:09,560
So thank you so much, Bharath, for coming on. And you and I went to autograph together.

809
01:23:09,560 --> 01:23:14,520
You know that there were way smarter people than I, than you and I.

810
01:23:14,520 --> 01:23:22,120
But you have I think smartness and intellect and intelligence is hard to define.

811
01:23:22,120 --> 01:23:27,880
But I would define it both by inherent talent and how you apply it.

812
01:23:27,880 --> 01:23:33,160
The application of that talent is more important than that talent.

813
01:23:33,160 --> 01:23:39,480
So by that metric, I would qualify you as very smart, Bharath.

814
01:23:39,480 --> 01:23:45,640
Right time, right place. Market has been good.

815
01:23:45,640 --> 01:23:50,680
Well, thanks so much for coming on, man. We'll have to do it with you sometime.

816
01:23:50,680 --> 01:24:10,520
Thanks, Rishabh.